<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9911">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05687669</url>
  </required_header>
  <id_info>
    <org_study_id>obstetric Renal prophylaxis</org_study_id>
    <nct_id>NCT05687669</nct_id>
  </id_info>
  <brief_title>Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICU</brief_title>
  <official_title>Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe pre-eclamptic toxemia has a high incidence of renal complications. Rapid diagnosis and&#xD;
      termination of pregnancy are still the gold standard main treatment for pre-eclampsia. Rapid&#xD;
      control of blood pressure showed to provide protection against many adverse effects of&#xD;
      preeclampsia as intracranial hemorrhage, subcapsular hepatic hematoma and acute kidney injury&#xD;
      (AKI).&#xD;
&#xD;
      In Assiut university hospital ICU regimen, glyceryl trinitrate (GTN) was used primarily for&#xD;
      this purpose. But it was accused in many cases as a cause for AKI without any other organ&#xD;
      damage along with the severe preeclampsia disease. Some previous studies supported this&#xD;
      assumption as , Ying-Hsuan .T. et.,al during their study of GTN on renal outcome during&#xD;
      cardiopulmonary bypass in cardiac surgery. Phentolamine infusion is a new rising alternative&#xD;
      for an old drug with a high safety profile.&#xD;
&#xD;
      In this research protocol the researchers will study comparative effect of glyceryl&#xD;
      trinitrate (GTN) versus phentolamine on renal outcome in severe pre-eclampsia patients during&#xD;
      their stay in obstetric ICU.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 12, 2023</start_date>
  <completion_date type="Anticipated">June 12, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 12, 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective study will be done in Assiut university hospital obstetric ICU, 2 groups will be examined and randomly assigned: group A using glyceryl trinitrate (GTN) to emergency control of blood pressure and group B using phentolamine infusion to control blood pressure. Each group consists of 85patients:</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Group(A): Glyceryl trinitrate (GTN) is labelled with &quot;Drug A&quot; on syringe pump. Group(B): Phentolamine is labelled with &quot;Drug B&quot; on syringe pump.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>kidney function tests</measure>
    <time_frame>96 hours after intervention</time_frame>
    <description>creatinine in micromoles per liter and urea in millimole per liter</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Pre-Eclampsia; Complicating Pregnancy</condition>
  <condition>Pre-eclampsia Aggravated</condition>
  <arm_group>
    <arm_group_label>Group GTN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Glyceryl trinitrates (GTN) is infused to patients with severe hypertensive preeclampsia till oral anti-hypertensives and Magnesium sulfate loadings lower blood pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Phentolamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phentolamine is infused to patients with severe hypertensive preeclampsia till oral anti-hypertensives and Magnesium sulfate loadings lower blood pressure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glyceryl trinitrate vs phentolamine for prophylaxis against renal impairment</intervention_name>
    <description>Glyceryl trinitrate vs phentolamine for prophylaxis against renal impairment</description>
    <arm_group_label>Group GTN</arm_group_label>
    <arm_group_label>Group Phentolamine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Severe preeclampsia defined by presentation of 2 or more of the following criteria:&#xD;
&#xD;
               1. Blood pressure more than 160/100&#xD;
&#xD;
               2. Proteinuria&#xD;
&#xD;
               3. Pitting edema&#xD;
&#xD;
               4. With or without organ dysfunctions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient relatives' refusal&#xD;
&#xD;
          2. Recent active internal hemorrhage&#xD;
&#xD;
          3. Chronic renal impairment or failure on dialysis for any other etiology&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>only in preeclampsia patients which is complicating pregnancy in females</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>December 7, 2022</study_first_submitted>
  <study_first_submitted_qc>January 7, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2023</study_first_posted>
  <last_update_submitted>January 7, 2023</last_update_submitted>
  <last_update_submitted_qc>January 7, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ayman Abd El-Khalek Mohammed Glala</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eclampsia</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Pregnancy Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phentolamine</mesh_term>
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

